The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Efficacy Biotech Master Fund Ltd. since 2007.
The trader's CIK number is 1366070.
At the time of the last reporting, Efficacy Biotech Master Fund Ltd. was the 10% Owner of Aeolus Pharmaceuticals, Inc.. (stock ticker symbol AOLS).
Also see all insider trading activities at Aeolus Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | RPRX | 0 | $0 | 542,903 | $369,898 | 0 | $0 |
| 2008 | RPRX | 2,331,688 | $15,950,721 | 302,057 | $2,783,355 | 0 | $0 |
| 2007 | RPRX | 783,500 | $7,784,855 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | AOLS | 0 | $0 | 4,057,214 | $2,527,000 | 0 | $0 |
2. Aeolus Pharmaceuticals, Inc. (AOLS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-12-21 | RPRX | Sale | 76,703 | .65 | 50,163 |
| 2009-12-18 | RPRX | Sale | 30,000 | .68 | 20,280 |
| 2009-12-17 | RPRX | Sale | 50,100 | .70 | 35,220 |
| 2009-12-11 | RPRX | Sale | 126,500 | .70 | 88,044 |
| 2009-12-14 | RPRX | Sale | 77,900 | .70 | 54,452 |
| 2009-12-15 | RPRX | Sale | 181,700 | .67 | 121,739 |
| 2008-10-24 | RPRX | Buy | 30,000 | 6.89 | 206,700 |
| 2008-10-23 | RPRX | Buy | 17,309 | 6.32 | 109,392 |
| 2008-10-27 | RPRX | Buy | 14,825 | 6.85 | 101,551 |
| 2008-10-17 | RPRX | Buy | 30,000 | 6.42 | 192,600 |
| 2008-10-17 | RPRX | Buy | 30,000 | 6.42 | 192,600 |
| 2008-10-10 | RPRX | Buy | 15,300 | 6.23 | 95,319 |
| 2008-10-13 | RPRX | Buy | 15,000 | 6.82 | 102,300 |
| 2008-10-02 | RPRX | Buy | 1,846,154 | 6.50 | 12,000,001 |
| 2008-03-18 | RPRX | Sale | 10,600 | 8.90 | 94,340 |
| 2008-03-17 | RPRX | Sale | 55,357 | 8.54 | 472,748 |
| 2008-03-27 | RPRX | Sale | 55,800 | 9.55 | 532,890 |
| 2008-03-26 | RPRX | Sale | 10,000 | 9.82 | 98,200 |
| 2008-03-14 | RPRX | Sale | 26,300 | 8.59 | 225,917 |
| 2008-03-24 | RPRX | Sale | 50,000 | 9.61 | 480,500 |
| 2008-03-20 | RPRX | Sale | 34,000 | 8.94 | 303,960 |
| 2008-03-25 | RPRX | Sale | 60,000 | 9.58 | 574,800 |
| 2008-03-12 | RPRX | Buy | 50,000 | 8.50 | 425,000 |
| 2008-03-10 | RPRX | Buy | 40,000 | 8.46 | 338,400 |
| 2008-03-07 | RPRX | Buy | 34,500 | 8.63 | 297,735 |
| 2008-02-28 | RPRX | Buy | 20,000 | 8.35 | 167,000 |
| 2008-02-29 | RPRX | Buy | 30,000 | 8.27 | 248,100 |
| 2008-01-04 | RPRX | Buy | 15,000 | 8.96 | 134,400 |
| 2008-01-07 | RPRX | Buy | 19,500 | 9.08 | 177,060 |
| 2007-12-31 | RPRX | Buy | 54,100 | 9.43 | 510,163 |
| 2007-12-28 | RPRX | Buy | 70,000 | 9.32 | 652,400 |
| 2007-12-20 | RPRX | Buy | 60,000 | 9.49 | 569,400 |
| 2007-12-21 | RPRX | Buy | 40,000 | 9.38 | 375,200 |
| 2007-12-19 | RPRX | Buy | 43,500 | 9.84 | 428,040 |
| 2007-12-18 | RPRX | Buy | 42,100 | 9.79 | 412,158 |
| 2007-12-13 | RPRX | Buy | 40,100 | 8.70 | 348,870 |
| 2007-12-14 | RPRX | Buy | 120,000 | 9.78 | 1,173,600 |
| 2007-12-05 | RPRX | Buy | 39,300 | 8.18 | 321,474 |
| 2007-12-06 | RPRX | Buy | 60,000 | 7.96 | 477,600 |
| 2007-12-03 | RPRX | Buy | 71,500 | 7.86 | 561,990 |
| 2007-12-04 | RPRX | Buy | 50,000 | 8.35 | 417,500 |
| 2007-10-22 | RPRX | Buy | 25,000 | 12.18 | 304,550 |
| 2007-10-19 | RPRX | Buy | 40,500 | 12.34 | 499,608 |
| 2007-10-18 | RPRX | Buy | 21,900 | 12.48 | 273,333 |
| 2007-10-17 | RPRX | Buy | 62,600 | 12.44 | 778,744 |
| 2007-10-25 | RPRX | Buy | 17,000 | 12.69 | 215,713 |
| 2007-10-23 | RPRX | Buy | 25,000 | 12.53 | 313,350 |
| 2007-10-24 | RPRX | Buy | 25,000 | 12.55 | 313,725 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-03-15 | AOLS | Sale | 193,234 | .76 | 146,857 |
| 2011-03-16 | AOLS | Sale | 3,799,380 | .61 | 2,317,621 |
| 2011-02-15 | AOLS | Sale | 7,000 | .95 | 6,650 |
| 2011-02-16 | AOLS | Sale | 57,600 | .97 | 55,872 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Efficacy Biotech Master Fund Ltd. (10% Owner of Aeolus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.